EMD Millipore, the life science business of Merck KGaA of Darmstadt, Germany, and Singulex, the developer and provider of Single Molecule Counting (SMC) technology for clinical diagnostics and scientific discovery, have entered into an agreement under which EMD Millipore will control and manage the Singulex Life Science Research business. Under the terms of the agreement, EMD Millipore will pay Singulex an upfront payment, royalties and additional payments based upon achievement of certain comme...